Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Immucor Launches Enhanced Customer Education Platform

Published: Wednesday, January 02, 2013
Last Updated: Wednesday, January 02, 2013
Bookmark and Share
Immucor LEARN is an effective, innovative solution which enables increased access to training and expert insights.

Immucor, Inc., has announced the launch of its innovative e-learning customer education platform, Lab Education And Resource Network (LEARN).

LEARN enables blood bank professionals to gain knowledge about their field and connect with peers through interactive case studies and online educational materials.

The LEARN platform is an important tool for those seeking to increase their blood bank knowledge and skills and it also allows them to earn P.A.C.E. credits.

"As a long-standing leader in blood bank diagnostics, Immucor is answering our customers' need for learning opportunities that increase flexibility and minimize costs and travel time. We turned to Knowledge Anywhere, a leader in education in the diagnostics market, to improve and expand upon our current customer education processes," said Bill Childs, Immucor's Director of North American Marketing.

"We previewed the LEARN System with our customers at the 2012 AABB Annual Meeting and received an overwhelming, positive response," Mr. Childs continues.

Mr. Childs continued, "We are happy to announce that LEARN is now generally available at our website. LEARN is unique in that it provides blood bank continuing education opportunities on-line at no charge for Immucor customers."

Through LEARN, Immucor will provide online courses and case studies from industry experts. The case studies allow blood bankers to comment, participate and learn from their peers' experiences.

LEARN can be accessed 24/7 via Immucor's Customer Center at www.immucor.com and provides blood bankers with the knowledge to advance the practice of transfusion medicine and improve patient outcomes.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Immucor Collaborates with Sirona Genomics
Partnership to bring NGS sample prep and bioinformatics offering designed specifically for HLA typing to the market.
Friday, October 10, 2014
FDA Approve Immucor MDx Test
PreciseType™ HEA test becomes the first-ever FDA-approved diagnostic for molecular typing of donor and recipient red blood cells for blood transfusions.
Friday, May 23, 2014
FDA Recommends Approval of Immucor's BeadChip Test
The Blood Products Advisory Committee recommends test as safe and effective for the molecular typing of human erythrocyte antigen (HEA) phenotypes in 35 blood group systems.
Wednesday, March 19, 2014
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!